SAN DIEGO, April 20, 2011 /PRNewswire/ — Aethlon Medical, Inc.
(OTCBB:AEMD), the pioneer in developing therapeutic filtration
devices to address infectious disease and cancer, disclosed today
that it is the subject of an ABC news story that can be accessed
online at: http://www.10news.com/news/27605561/detail.html
(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)
About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address
infectious disease and cancer. Our devices are designed to be novel
platform solutions that fill therapeutic voids or aid in disease
diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively
target the removal of infectious viruses and immunosuppressive
proteins from the entire circulatory system. We recently discovered
that our Hemopurifier® captures tumor-secreted exosomes that
suppress the immune system of those afflicted with cancer. Prior to
this discovery, a therapeutic strategy to directly inhibit or
reverse the immunosuppressive destruction caused by exosomes did
not exist in cancer care. By eliminating this mechanism, we believe
our Hemopurifier® can fill an unmet clinical need and provide
the benefit of an immune-based therapy without adding drug toxicity
or interaction risks to established and emerging treatment
strategies.
Human studies have documented the ability of our
Hemopurifier® to safely reduce viral load in both Hepatitis-C
virus (HCV) and Human Immunodeficiency Virus (HIV) infected
patients without the administration of antiviral drugs.
However, our initial clinical and commercialization focus is
to establish our Hemopurifier® as an adjunct therapy to enhance
the benefit of both infectious disease and cancer treatment
regimens. In this regard, we
‘/>”/>
SOURCE
